1 800 211 715 – Raffle hotline number

You are currently browsing:

Apollo Aviation Supports Breast Cancer Ireland

Apollo Aviation organises an annual football tournament each summer to raise funds to support Breast Cancer Ireland. We would like to express our full gratitude for their fundraising efforts, which to date has raised €78,000. Thank you so much for your support – you are true BCI heroes!

Read More

Exosomes – Delivering Surprises in Breast Cancer Research

“Researchers have made a discovery relating to how breast cancer cells prevent the immune system from attacking tumours.” Could this research, part-funded by Breast Cancer Now, be a turning point in the fight against breast cancer? To read more about this, please click on the below link: https://bit.ly/2VRuYfU

Read More

Lobular breast cancer comes into the research spotlight

Breast Cancer Ireland fully supports new research being undertaken by Fred Hutch (aka the Fred Hutchinson Cancer Research Center, based in Seattle, USA) into lobular breast cancer, which accounts for 10%-15% of invasive breast cancers. It is harder to detect and generally understudied, which is why this research is so important. For further details, please […]

Read More

Antibody discovery offers breakthrough in breast cancer fight

A research team at King’s College London has found that “targeted antibody therapies could bring long-awaited advances for those with triple-negative breast cancer.” Breakthroughs like these are exactly why breast cancer research is so important. To read more on this, please click the below link: https://bit.ly/2GZSEvo

Read More

DPYSL3 an outlier gene in triple-negative breast cancer

Breast Cancer Ireland is delighted with new research from Baylor College of Medicine (based in Houston, Texas, USA) that highlights DPYSL3 as an outlier gene in triple-negative breast cancer. It is typically associated with younger women diagnosed and for whom traditional standard treatments are generally prescribed. There is a great need for continued investment into […]

Read More
X